Arabian Cement Company (ARCC)
Egyptian Exchange · Egypt · prices in EGP · close of 27 Oct 2026
Key indicators
| Last close | EGP 64.00 |
|---|---|
| 52-week range | 44.13 – 91.72 |
| Return, 1 month / 3 months | +1.1% / +13.1% |
| Return, 1 year / 3 years | +35.9% / +529.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -25.6% |
| Average daily value traded | 64.86M EGP |
| Dividend yield | 12.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arabian Cement Company is an Egyptian manufacturer of cement and clinker based in Cairo. It produces grey cement for use in concrete and building work, supplying construction companies, contractors and distributors. The company serves customers in its home market of Egypt and also exports cement and clinker to buyers abroad. Its operations cover quarrying raw materials, producing clinker in kilns and grinding it into finished cement, which is then packed and dispatched to customers.
Arabian Cement Company trades under the code ARCC on the Egyptian Exchange in Egypt, with its price quoted in Egyptian pounds (EGP). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arabian Cement Company (ARCC) trades on the Egyptian Exchange in Egypt. It last closed at EGP 64.00 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 34 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.9% and over the last three months it rose 13.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.9% | ||
| From 52-week high | -20.8% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.1% | ||
| 6-month return | 19.9% | ||
| 12-month return, skipping the last month | 34.4% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.6% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 64.86M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 12.9% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.0% |
|---|---|
| 1 month | +1.1% |
| 3 months | +13.1% |
| 6 months | +19.9% |
| 1 year | +35.9% |
| 3 years | +529.3% |
| 5 years | +1,682.7% |
Signals
| 50-day / 200-day average | 70.83 / 57.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Apr 2026 | EGP 5.3400 |
| 22 Dec 2025 | EGP 2.9400 |
| 8 Jan 2025 | EGP 1.5850 |
| 9 Jan 2024 | EGP 0.2620 |
| 10 Jan 2023 | EGP 0.6600 |
| 17 Dec 2019 | EGP 0.4700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.